ReviewAutoimmune diseases and immune-checkpoint inhibitors for cancer therapy: review of the literature and personalized risk-based prevention strategy
Under an Elsevier user license
open archive
Key words
autoimmune disorders
checkpoint inhibitors
CTLA-4
immune-related adverse events
solid organ transplantation recipients
Cited by (0)
© 2020 European Society for Medical Oncology. Published by Elsevier Ltd.